Wednesday, December 31, 2025 12/31/2025

Optically Promoting Cardiac Maturation Using Engineered Peptides

Award Number: R01HL164348
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2023
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Optically Promoting Cardiac Maturation Using Engineered Peptides - PROJECT SUMMARY The promise of human stem cell-derived cardiomyocytes (hSC-CMs) opens doors towards the feasibility of personalized medicine against cardiac diseases and for performing more accurate drug discovery studies. Moreover, hSC-CMs overcome the issue of species differences when using animal models for high throughput screening studies. However, one of the bottlenecks for scaling up the use of hSC-CMs is their ability to accurately reflect the native structure and function of adult human cardiomyocytes. Current efforts to address this critical challenge involve maturation protocols that use biophysical cues such as electrical stimulation or substrate- induced tissue alignment. Methods for electrical stimulation often utilize electrode contacts for field stimulation, bulky instrumentation for combining electrical stimuli delivery with mechanical or sustained chemical stimulation, or genetically modifying cells to be light-responsive. Although we have seen successes through these induction and stimulation approaches, the field would benefit from a stimulation approach with minimal culture contact to reduce risk of infection during long-term cultures, as well as a light-based approach with higher spatiotemporal resolution than electrode-based stimulation. Here, we propose a new paradigm for stimulating hSC-CMs towards maturation by interfacing these cells with peptide-based substrates that can induce tissue anisotropy and are engineered to convert light to stimulatory cues. Our team will develop peptides functionalized with chromophore units and cell-binding epitopes as materials that can be used for light-based stimulation of hSC- CMs, in combination with induction of tissue alignment, towards maturation. The long-term goal of this project is to establish light stimulation via engineered peptides as a viable method to stimulate cardiomyocytes and promote hSC-CM maturation in an electrodeless and non-genetic manner. We hypothesize that transient charging and other associated light-induced processes at the cardiomyocyte-biomaterial interface can influence extracellular potential, resulting in the photostimulation of hSC-CMs towards maturation. Our rationale for proposing a materials-based approach for stimulating hSC-CMs stems from previous reports of conjugated polymers being used as a photoactive substrate for triggering action potentials of other excitable cells. To test our hypothesis, we propose the following specific aims: (1) establishing design parameters for engineered peptide substrates with optimal photostimulation efficiency; (2) test the cellular- and tissue-level impact of peptide-mediated photostimulation in combination with anisotropic cues; and (3) elucidate the effect of the proposed photostimulation method, along with anisotropy cues, on hSC-CM maturation. By establishing the design rules for the proposed photoexcitable peptides for eliciting combinatorial cues to stimulate hSC-CMs and ensure their capability to excite cardiac cells, this innovative approach offers a new strategy for a “wireless” stimulation of cardiac tissues towards maturation, and can therefore significantly contribute towards addressing the grand challenge of immaturity of stem cell-derived cardiomyocytes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	000	3	12/3/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $599,500 )
2025	2025	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	003	3	8/15/2025	SUPPLEMENT FOR EXPANSION	$79,985
2025	2025	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	002	3	7/30/2025	NON-COMPETING CONTINUATION	$519,515
2025	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	001	2	7/8/2025	SUPPLEMENT FOR EXPANSION	$0
2025	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	000	2	6/4/2025	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $599,500

Issue Date FY: 2024 ( Subtotal = $612,722 )
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	000	1	3/12/2024	SUPPLEMENT FOR EXPANSION	$44,640
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	003	1	9/25/2024	SUPPLEMENT FOR EXPANSION	$0
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	004	2	9/25/2024	SUPPLEMENT FOR EXPANSION	$82,177
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	002	2	9/25/2024	NON-COMPETING CONTINUATION	$0
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	001	2	6/27/2024	NON-COMPETING CONTINUATION	$485,905
														Subtotal = $612,722

Issue Date FY: 2023 ( Subtotal = $501,245 )
2023	2023	UNIVERSITY OF CALIFORNIA, IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Cardiovascular Diseases Research	000	1	4/26/2023	NEW	$501,245
														Subtotal = $501,245

Grand Total All Awards = $1,713,467

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Optically Promoting Cardiac Maturation Using Engineered Peptides

Award Number: R01HL164348

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2023

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer